Hu Xiaowei, Hawthorne Wayne J, Buhler Leo
Division of Anaesthesiology, Department of Acute Care Medicine, Geneva University Hospitals, Geneva, Switzerland.
Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
Transplantation. 2025 Aug 1;109(8):1329-1334. doi: 10.1097/TP.0000000000005367. Epub 2025 Apr 8.
The global demand for organ transplantation outpaces supply, necessitating innovative solutions. Xenotransplantation, using animal organs, cells, and tissues, is a promising solution to address the organ shortage. The World Health Organization and the International Xenotransplantation Association collaboratively established an online inventory in 2006 ( www.humanxenotransplant.org ) to catalog human xenotransplantation practices. The inventory, managed successively by the Geneva University Hospital and the Sichuan Provincial People's Hospital, aligns with the World Health Organization directives for transparency and best practices in the field of transplantation. Relevant data have been regularly collected from numerous sources (scientific publications, congresses, press articles, and declarations of International Xenotransplantation Association members) by a dedicated team in Switzerland and China, ensuring rigorous verification. The initial information is used to create a first entry in the database, which is then completed when more details become available. As of May 2024, the inventory contained 54 entries of distinct xenotransplantation procedures undertaken on humans. From these data, various trends can be observed over the past 2 decades regarding the type of transplantation, their regulation status, and the source animal. Notably, recent high-profile cases of solid organ transplantation involving kidneys and hearts were made feasible through years of progressive xenotransplantation research and ongoing changes to regulations. Recent clinical applications of solid organ xenotransplantation suggest that more clinical procedures may soon follow for patients with end-stage kidney or heart disease or diabetes. Future perspectives advocate for increased funding and expansion of the current registry or its potential integration into a larger and more broadly internationally recognized registry, such as the Global Observatory on Donation and Transplantation.
全球对器官移植的需求超过了供应,因此需要创新解决方案。异种移植,即使用动物器官、细胞和组织,是解决器官短缺问题的一个有前景的办法。世界卫生组织和国际异种移植协会于2006年合作建立了一个在线清单(www.humanxenotransplant.org),以编目人类异种移植实践。该清单先后由日内瓦大学医院和四川省人民医院管理,符合世界卫生组织关于移植领域透明度和最佳实践的指令。瑞士和中国的一个专门团队定期从众多来源(科学出版物、大会、新闻文章和国际异种移植协会成员的声明)收集相关数据,确保严格核查。初始信息用于在数据库中创建第一个条目,当有更多详细信息时再进行补充。截至2024年5月,该清单包含54项针对人类进行的不同异种移植程序的条目。从这些数据中,可以观察到过去20年在移植类型、监管状态和供体动物来源方面的各种趋势。值得注意的是,近年来涉及肾脏和心脏的实体器官移植备受瞩目的案例,是经过多年渐进性异种移植研究以及法规的不断变化才得以实现的。实体器官异种移植最近的临床应用表明,终末期肾病、心脏病或糖尿病患者可能很快会有更多的临床程序。未来的展望主张增加资金投入,扩大当前的登记册,或者可能将其整合到一个更大、更广泛被国际认可的登记册中,比如全球捐赠与移植观察站。